MENIN INHIBITORS

Clinical trials for MENIN INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new MENIN INHIBITORS trials appear

Sign up with your email to follow new studies for MENIN INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough leukemias: targeted pill BN104 enters human trials

Disease control Ongoing

This study tests a new drug called BN104 in 66 adults with acute leukemia that has come back or not responded to other treatments. The drug targets specific genetic changes (KMT2A or NPM1 mutations) to try to control the disease. The goal is to find the safest dose and see if it …

Matched conditions: MENIN INHIBITORS

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) • Aim: Disease control

Last updated May 17, 2026 04:15 UTC

MENIN INHIBITORS

Get alerted when new MENIN INHIBITORS trials appear

New hope for tough leukemias: targeted pill BN104 enters human trials